Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The Celiac Disease Treatment Market?

The market size for celiac disease treatment has experienced robust growth recently. A rise from $0.61 billion in 2024 to an anticipated $0.66 billion in 2025, mirroring a compound annual growth rate (CAGR) of 8.8%, is predicted. This growth during the historic era is attributed to increasing incidences of celiac disease, amplified awareness and diagnosis rates, and burgeoning demand for non-dietary treatment methods. In addition, factors like the strong pipeline of pioneering therapies, favorable regulatory guidelines, and higher investments from pharmaceutical firms also contribute to the market expansion.

Predictions indicate a robust growth for the celiac disease treatment market in the upcoming years, with a forecasted surge to $0.94 billion in 2029 at a 9.3% compound annual growth rate (CAGR). The expected growth over this forecast period can be associated with the increasing global occurrence of celiac disease, heightened rates of awareness and diagnosis, ongoing clinical studies for new treatments, a rise in the demand for gluten-free options, regulatory initiatives backing orphan diseases, and the escalating costs of healthcare. The forecast period is also likely to witness major trends such as the introduction of innovative non-dietary therapies, advancements in enzyme supplements, personalized treatment strategies, development of peptide-based immunotherapies, enhanced diagnostic tools, and progress in clinical trials.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

What External And Internal Drivers Are Influencing The Celiac Disease Treatment Market?

The escalation in the occurrence of diabetes is predicted to stimulate the expansion of the celiac disease treatment market in the future. Being unable to properly control blood sugar or glucose levels is a characteristic of this chronic health issue. The growing incidence of diabetes is rooted in the overlapping dietary management needs it shares with celiac disease. This includes the careful monitoring of food intake to manage blood sugar levels and to avoid complications. The adoption of a gluten-free diet in celiac disease treatment can contribute to improved digestive wellness and nutrient absorption, which in turn helps better blood sugar control and lessens complications for those managing both conditions. A case in point, in June 2024, data from the National Health Service, a UK government department, verified that around 3,615,330 individuals who registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023. This is an 18% climb from 3,065,825 cases in 2022. Hence, the climbing occurrence of diabetes is fuelling the growth of the celiac disease treatment market.

How Is The Celiac Disease Treatment Market Organized By Different Segments?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue

3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

What Current And Upcoming Trends Are Shaping The Celiac Disease Treatment Market?

Key players in the treatment market for celiac disease are prioritizing the development of oral treatment options, like small molecule therapies. These are intended to specifically target and neutralize immune reactions to gluten, thereby improving patient compliance and presenting an alternative to rigorous gluten-free diets. Small molecule therapies are diminutive drugs that can infiltrate cells directly in order to treat proteins or enzymes causing disease. To illustrate, Immunic Inc., a biotech corporation based in the United States introduced IMU-856 in February 2025. IMU-856 is a small molecule that amplifies the production of the glucagon-like peptide-1 (GLP-1) in our bodies, which enhances the function of the intestinal barrier in individuals with celiac disease. It also boosts the body’s capability of absorbing nutrients and reduces symptoms without negatively affecting immune activity.

Who Are The Global Leaders Steering The Celiac Disease Treatment Market Forward?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

How Do Regional Dynamics Influence The Celiac Disease Treatment Market Performance?

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model